Company intelligence / Profile preview

Matsutani Chemical Industry

Itami, Hyogo, Japan

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Matsutani has successfully commercialized dietary fibers (Fibersol-2) and rare sugars (notably allulose, branded ASTRAEA) with established use for food, beverage, and health benefit applications. Peer-reviewed and regulatory-passed; patents exist for new pharmaceutical and functional food compositions targeting GLP-1 stimulation, digestion modulation, and neurological endpoints[4][7][8].

Therapeutic areas: Metabolic DisordersEndocrinologyPsychiatry
Modalities: Small moleculeCarbohydrateDietary fiber
Industry: Biotech

Partnerships

Academic partnership with Japanese universities for rare sugar developmentFOSHU approval partnerships (Japan regulatory bodies)

Beyond the preview

Go deeper on Matsutani Chemical Industry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matsutani Chemical Industry.

Explore the full profile